DYNLL1-related cytoskeletal rearrangement and tumor cell migration can be theoretically inhibited by anti-HGF therapy, as DYNLL1 shows indirect interaction with HGF in HGF/c-MET pathway in HNSCC. This evidence concerns the gene MET and neoplasm.